Showing results (1-10 of 409) with videos related to
Sort By:
Pageof 41
Journal of the National Cancer Institute|February 7, 2001
Development of matrix metalloproteinase inhibitors in cancer therapyM Hidalgo, S G EckhardtOncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan: a review of the initial phase I trialsS G EckhardtInvestigational New Drugs|January 1, 1997
Development of angiogenesis inhibitors for cancer therapyS G Eckhardt, J M PludaAnti-Cancer Drugs|December 10, 1999
Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming unitsM Hidalgo, E Izbicka, S G Eckhardt, et al.Journal of Virology|February 1, 1991
Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminusS G Eckhardt, D R Milich, A McLachlanJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory propertiesA W Tolcher, S G Eckhardt, J Kuhn, et al.Journal of Equine Veterinary Science|January 10, 2025
Sperm vitrification in horses and donkeysM HidalgoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignanciesE K Rowinsky, R Humphrey, L A Hammond, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
New insights into pancreatic cancer biologyM HidalgoPageof 41